» Articles » PMID: 27846599

Potent Protection Against H5N1 and H7N9 Influenza Via Childhood Hemagglutinin Imprinting

Overview
Journal Science
Specialty Science
Date 2016 Nov 16
PMID 27846599
Citations 268
Authors
Affiliations
Soon will be listed here.
Abstract

Two zoonotic influenza A viruses (IAV) of global concern, H5N1 and H7N9, exhibit unexplained differences in age distribution of human cases. Using data from all known human cases of these viruses, we show that an individual's first IAV infection confers lifelong protection against severe disease from novel hemagglutinin (HA) subtypes in the same phylogenetic group. Statistical modeling shows that protective HA imprinting is the crucial explanatory factor, and it provides 75% protection against severe infection and 80% protection against death for both H5N1 and H7N9. Our results enable us to predict age distributions of severe disease for future pandemics and demonstrate that a novel strain's pandemic potential increases yearly when a group-mismatched HA subtype dominates seasonal influenza circulation. These findings open new frontiers for rational pandemic risk assessment.

Citing Articles

Immune history shapes human antibody responses to H5N1 influenza viruses.

Garretson T, Liu J, Li S, Scher G, Santos J, Hogan G Nat Med. 2025; .

PMID: 40082696 DOI: 10.1038/s41591-025-03599-6.


Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity.

Le Sage V, Werner B, Merrbach G, Petnuch S, OConnell A, Simmons H Emerg Infect Dis. 2025; 31(3):477-487.

PMID: 40023796 PMC: 11878318. DOI: 10.3201/eid3103.241485.


Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis and Transmission of Human Influenza A(H5N1) Clade 2.3.4.4b Virus in Ferret Model.

Sun X, Belser J, Li Z, Brock N, Pulit-Penaloza J, Kieran T Emerg Infect Dis. 2025; 31(3):458-466.

PMID: 40023783 PMC: 11878296. DOI: 10.3201/eid3103.241489.


Preparedness, prevention and control related to zoonotic avian influenza.

Alvarez J, Boklund A, Dippel S, Dorea F, Figuerola J, Herskin M EFSA J. 2025; 23(1):e9191.

PMID: 39882189 PMC: 11775931. DOI: 10.2903/j.efsa.2025.9191.


Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice.

Hawman D, Tipih T, Hodge E, Stone E, Warner N, McCarthy N Nat Commun. 2025; 16(1):655.

PMID: 39809744 PMC: 11732985. DOI: 10.1038/s41467-024-55546-7.


References
1.
Terajima M, Co M, Ennis F . Age and different influenza viruses. Lancet Infect Dis. 2014; 14(2):101. PMC: 4114033. DOI: 10.1016/S1473-3099(13)70698-4. View

2.
Miller M, Gardner T, Krammer F, Aguado L, Tortorella D, Basler C . Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013; 5(198):198ra107. PMC: 4091683. DOI: 10.1126/scitranslmed.3006637. View

3.
Housworth J, Langmuir A . Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974; 100(1):40-8. DOI: 10.1093/oxfordjournals.aje.a112007. View

4.
Alling D, Blackwelder W, Stuart-Harris C . A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1981; 113(1):30-43. DOI: 10.1093/oxfordjournals.aje.a113063. View

5.
Worobey M, Han G, Rambaut A . Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U S A. 2014; 111(22):8107-12. PMC: 4050607. DOI: 10.1073/pnas.1324197111. View